Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors

dc.creatorSangenito, Leandro Stefano
dc.creatord’Avila-Levy, Claudia Masini
dc.creatorBranquinha, Marta Helena
dc.creatorSantos, André Luis Souza dos
dc.date.accessioned2022-03-21T18:05:36Z
dc.date.accessioned2023-09-05T12:08:29Z
dc.date.available2022-03-21T18:05:36Z
dc.date.available2023-09-05T12:08:29Z
dc.date.created2022-03-21T18:05:36Z
dc.date.issued2022
dc.identifierSANGENITO, Leandro Stefano et al. Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 117, e210386, p. 1-7, 2022.
dc.identifier0074-0206
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/51782
dc.identifier10.1590/0074-02760210386
dc.identifier1678-8060
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8650236
dc.languageeng
dc.publisherFiocruz/IOC
dc.rightsopen access
dc.titleRepositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors
dc.typeArticle


Este ítem pertenece a la siguiente institución